• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Final Rule on Covered Outpatient Drugs


January 29, 2016.

The advanced copy of the Final Rule on Covered Outpatient Drugs has been released by CMS.

Reserve your spot at CBI’s Final Rule Forum, February 22 in Philadelphia, to gain timely and critical insight into policy changes, operational implications, strategic impacts and best practices for compliance. CMS provides a Keynote Address, and leading manufacturers dive into the nuances of operationalizing the rule, providing a valuable opportunity to benchmark progress and key milestones in advance of the April 1 effective date.

Learn more at www.cbinet.com/finalrule


Recent Videos
Related Content